Galecto, Inc. (GLTO)

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.94	14.18	21.47	32.79	62.56	163.58
Short-Term Investments	-	-	11.69	27.44	37.63	-
Cash & Short-Term Investments	11.94	14.18	33.15	60.22	100.19	163.58
Cash Growth	-56.06%	-57.24%	-44.95%	-39.89%	-38.75%	1348.40%
Other Receivables	0.92	0.88	1.72	1.38	2.28	2.21
Receivables	0.92	0.88	1.72	1.38	2.28	2.21
Prepaid Expenses	0.41	0.59	0.77	0.81	1.73	1.64
Other Current Assets	1.65	1.19	1.13	1.5	5.9	1.86
Total Current Assets	14.92	16.84	36.77	63.91	110.1	169.3
Property, Plant & Equipment	0.13	0.13	0.33	1.17	1.04	0.89
Long-Term Investments	-	-	-	5.83	9.05	-
Other Long-Term Assets	0.32	0.16	1.13	2.28	2.03	1.42
Total Assets	15.37	17.13	38.23	73.19	122.22	171.6
Accounts Payable	0.35	0.38	1.7	3.35	1.53	2.85
Accrued Expenses	0.73	0.32	1.67	6.74	2.18	2
Current Portion of Leases	0.01	0.01	0.18	0.48	0.4	0.37
Other Current Liabilities	0.46	0.49	2.27	0.54	0.44	0.34
Total Current Liabilities	1.55	1.2	5.83	11.11	4.54	5.57
Long-Term Leases	0.06	0.06	0.07	0.33	0.45	0.54
Other Long-Term Liabilities	0.05	0.04	-	-	-	-
Total Liabilities	1.66	1.3	5.9	11.44	4.99	6.11
Additional Paid-In Capital	292.11	291.9	288.04	279.73	273.66	269.18
Retained Earnings	-280.06	-277.52	-256.09	-217.74	-156.11	-104.36
Comprehensive Income & Other	0.3	0.1	0.38	-0.24	-0.32	0.67
Total Common Equity	12.35	14.47	32.33	61.75	117.22	165.49
Shareholders' Equity	13.71	15.83	32.33	61.75	117.22	165.49
Total Liabilities & Equity	15.37	17.13	38.23	73.19	122.22	171.6
Total Debt	0.07	0.07	0.25	0.8	0.85	0.92
Net Cash (Debt)	11.87	14.1	32.9	65.25	108.39	162.67
Net Cash Growth	-56.08%	-57.14%	-49.58%	-39.80%	-33.37%	1379.33%
Net Cash Per Share	9.75	12.19	30.96	64.20	107.27	889.34
Filing Date Shares Outstanding	1.32	1.32	1.08	1.03	1.01	1.01
Total Common Shares Outstanding	1.32	1.32	1.08	1.03	1.01	1.01
Working Capital	13.37	15.64	30.94	52.8	105.56	163.73
Book Value Per Share	9.34	10.99	29.81	60.18	116.01	163.77
Tangible Book Value	12.35	14.47	32.33	61.75	117.22	165.49
Tangible Book Value Per Share	9.34	10.99	29.81	60.18	116.01	163.77
Machinery	0.11	0.11	0.11	0.42	0.22	-

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q